Competition Heats Up For Beijing’s Vaccine Market
This article was originally published in PharmAsia News
Executive Summary
Beijing, the first city to initiate free hepatitis A vaccination for children under China's nationwide immunity plan, has given the green light to GlaxoSmithKline and local enterprise Sinovac Biotech to provide inactivated hepatitis A vaccine. The two companies will effectively corner the Beijing free hepatitis A vaccine market for three years. According to public information, Sanofi Pasteur, GSK and Merck Sharpe & Dhome supply half of the paid vaccine market in the city. Officials at the China Association of Pharmaceutical Commerce believe foreign corporations will face fierce competitive bidding from domestic companies. Last year, Sanofi Pasteur was the only multinational company out of five pharmaceutical firms who won the tender for supplying Beijing with flu vaccine. (Click here for more - Chinese Language)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.